GLIA: A novel drug discovery target for clinical pain

This publication has 111 references indexed in Scilit:

• Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury
  Published by Elsevier ,2003
• Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease
  Gut, 2002
• Complete Resolution of Reflex Sympathetic Dystrophy With Thalidomide Treatment
  Archives of internal medicine (1960), 2001
• lnterleukin-10 in the Brain
  Critical Reviews in Immunology, 2001
• Neuronal Plasticity: Increasing the Gain in Pain
  Science, 2000
• ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL-10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGM
  Shock, 2000
• Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: Evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis
  Arthritis & Rheumatism, 2000
• Dynamic regulation of the proinflammatory cytokine, interleukin-1β: Molecular biology for non-molecular biologists
  Life Sciences, 1999
• Thalidomide Inhibits Tumor Necrosis Factor- Production by Lipopolysaccharide- and Lipoarabinomannan-Stimulated Human Microglial Cells
  The Journal of Infectious Diseases, 1995
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993